LIVE QUOTE
Henry Schein, Inc. HSIC
Healthcare · Medical - Distribution · NASDAQ
$72.70
Market Cap$8.0B
P/E Ratio14.0
Beta0.85
Employees25,000

Investment Thesis

. Conversely, positive earnings surprises or significant market share gains could reinforce the bullish stance, supporting increased allocations.

Competitive Moat

characterized by significant scale economies and customer switching costs. The company's extensive distribution network and established relationships with healthcare providers create a formidable barrier to entry for new competitors. Additionally, HSIC's brand recognition and regulatory compliance in healthcare distribution solidify its position. Over the next 5-10 years, this moat appears durable, although the rise of direct-to-consumer models and specialized competitors poses a moderate threat to its market share.

Growth Engine

Future revenue growth for HSIC is expected to stem primarily from the expanding total addressable market (TAM) in healthcare distribution, driven by increasing healthcare expenditures and an aging population. The company is well-positioned to leverage its existing customer base, enhancing organic growth through value-added services and technology solutions. Moreover, HSIC's strategic acquisitions can fuel growth, especially in high-margin segments like practice management software. Currently, HSIC is gaining market share in the dental supplies sector, bolstered by innovative product launches and enhanced customer service offerings.

This analysis is AI-generated using publicly available market data and is for informational purposes only. It does not constitute investment advice. Always conduct your own research before making investment decisions.
Morningstar Investor
Analyst ratings, fair value, moat
Research HSIC
Robinhood
$0 commission trades
Trade HSIC
Webull
Extended-hours, options, charts
Trade HSIC
TradingView
Advanced charts & screeners
Chart HSIC
We may earn a commission if you open an account through our links, at no extra cost to you.
Loading chart...

Frequently Asked Questions

As of 2026-04-16, HSIC's P/E ratio is not available, which may indicate that the stock is either unprofitable or not yet valued in a traditional sense. Additionally, without a market cap provided, it's difficult to assess its relative size in the healthcare distribution sector.
HSIC does not currently pay a dividend, as there is no dividend yield information available.
HSIC operates in the Healthcare sector, specifically within the Medical - Distribution industry.
The market cap for HSIC is not provided, making it impossible to classify its size; generally, companies can be categorized as mega-cap, large-cap, mid-cap, small-cap, or micro-cap based on their market capitalization.
HSIC's competitors in the medical distribution industry include companies like McKesson Corporation and Cardinal Health, which also provide healthcare products and services.
FAQ generated 2026-04-16

Related Reading

Related Stocks

← View in Stock Screener
Disclaimer: Stock data sourced from Financial Modeling Prep, updated daily. Prices may be delayed. Interactive charts powered by TradingView. This page is for informational and educational purposes only and does not constitute investment advice. We are not licensed financial advisors. Past performance is not indicative of future results. All investments carry risk, including the possible loss of principal. Please consult a qualified professional before making investment decisions.

Privacy Policy · Terms